US Stock MarketDetailed Quotes

CMPX Compass Therapeutics

Watchlist
  • 2.120
  • +0.050+2.42%
Close Apr 24 16:00 ET
  • 2.100
  • -0.020-0.94%
Post 20:01 ET
293.16MMarket Cap-5.89P/E (TTM)

Compass Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
850K
0
0
850K
0
0
0
0
0
0
Operating revenue
--850K
--0
--0
--850K
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
14.12%57.48M
7.67%16.57M
2.62%12.24M
19.18%15.9M
31.50%12.77M
20.91%50.36M
19.44%15.39M
-5.33%11.93M
48.40%13.34M
35.21%9.71M
Selling and administrative expenses
23.61%15.13M
19.18%3.54M
17.19%3.63M
51.61%4.72M
5.69%3.25M
5.02%12.24M
0.24%2.97M
10.26%3.1M
-0.35%3.11M
11.06%3.07M
-General and administrative expense
23.61%15.13M
19.18%3.54M
17.19%3.63M
51.61%4.72M
5.69%3.25M
5.02%12.24M
0.24%2.97M
10.26%3.1M
-0.35%3.11M
11.06%3.07M
Research and development costs
11.08%42.34M
4.93%13.04M
-2.48%8.61M
9.30%11.17M
43.45%9.52M
27.08%38.12M
25.16%12.43M
-9.80%8.83M
74.39%10.22M
50.35%6.64M
Operating profit
-12.43%-56.63M
-7.67%-16.57M
-2.62%-12.24M
-12.81%-15.05M
-31.50%-12.77M
-20.91%-50.36M
-19.44%-15.39M
5.33%-11.93M
-48.40%-13.34M
-35.21%-9.71M
Net non-operating interest income expense
-7.59%7.3M
-20.81%1.59M
-10.40%1.76M
-4.37%1.97M
234.75%7.9M
55.26%2.01M
214.93%1.96M
385.61%2.06M
Non-operating interest income
-7.59%7.3M
-20.81%1.59M
-10.40%1.76M
-4.37%1.97M
----
234.75%7.9M
55.26%2.01M
214.93%1.96M
385.61%2.06M
----
Other net income (expense)
-61.29%-50K
5.82%1.98M
-144.29%-31K
9,270.00%1.87M
Special income (charges)
----
----
----
--0
----
----
----
----
--0
----
-Gain on sale of property,plant,equipment
----
----
----
--0
----
----
----
----
--0
----
Other non- operating income (expenses)
-61.29%-50K
----
----
----
5.82%1.98M
---31K
----
----
----
9,270.00%1.87M
Income before tax
-16.19%-49.38M
-12.06%-15.03M
-5.19%-10.48M
-15.94%-13.08M
-37.64%-10.79M
-8.33%-42.49M
-15.71%-13.42M
16.79%-9.96M
-32.78%-11.28M
-9.42%-7.84M
Income tax
0
0
0
0
0
0
Net income
-16.19%-49.38M
-12.06%-15.03M
-5.19%-10.48M
-15.94%-13.08M
-37.64%-10.79M
-8.33%-42.49M
-15.71%-13.42M
16.79%-9.96M
-32.78%-11.28M
-9.42%-7.84M
Net income continuous Operations
-16.19%-49.38M
-12.06%-15.03M
-5.19%-10.48M
-15.94%-13.08M
-37.64%-10.79M
-8.33%-42.49M
-15.71%-13.42M
16.79%-9.96M
-32.78%-11.28M
-9.42%-7.84M
Minority interest income
Net income attributable to the parent company
-16.19%-49.38M
-12.06%-15.03M
-5.19%-10.48M
-15.94%-13.08M
-37.64%-10.79M
-8.33%-42.49M
-15.71%-13.42M
16.79%-9.96M
-32.78%-11.28M
-9.42%-7.84M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-16.19%-49.38M
-12.06%-15.03M
-5.19%-10.48M
-15.94%-13.08M
-37.64%-10.79M
-8.33%-42.49M
-15.71%-13.42M
16.79%-9.96M
-32.78%-11.28M
-9.42%-7.84M
Basic earnings per share
-9.09%-0.36
-10.00%-0.11
0.00%-0.08
-11.11%-0.1
-33.33%-0.08
10.81%-0.33
0.00%-0.1
33.33%-0.08
-12.50%-0.09
14.29%-0.06
Diluted earnings per share
-9.09%-0.36
-10.00%-0.11
0.00%-0.08
-11.11%-0.1
-33.33%-0.08
10.81%-0.33
0.00%-0.1
33.33%-0.08
-12.50%-0.09
14.29%-0.06
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 850K00850K000000
Operating revenue --850K--0--0--850K--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 14.12%57.48M7.67%16.57M2.62%12.24M19.18%15.9M31.50%12.77M20.91%50.36M19.44%15.39M-5.33%11.93M48.40%13.34M35.21%9.71M
Selling and administrative expenses 23.61%15.13M19.18%3.54M17.19%3.63M51.61%4.72M5.69%3.25M5.02%12.24M0.24%2.97M10.26%3.1M-0.35%3.11M11.06%3.07M
-General and administrative expense 23.61%15.13M19.18%3.54M17.19%3.63M51.61%4.72M5.69%3.25M5.02%12.24M0.24%2.97M10.26%3.1M-0.35%3.11M11.06%3.07M
Research and development costs 11.08%42.34M4.93%13.04M-2.48%8.61M9.30%11.17M43.45%9.52M27.08%38.12M25.16%12.43M-9.80%8.83M74.39%10.22M50.35%6.64M
Operating profit -12.43%-56.63M-7.67%-16.57M-2.62%-12.24M-12.81%-15.05M-31.50%-12.77M-20.91%-50.36M-19.44%-15.39M5.33%-11.93M-48.40%-13.34M-35.21%-9.71M
Net non-operating interest income expense -7.59%7.3M-20.81%1.59M-10.40%1.76M-4.37%1.97M234.75%7.9M55.26%2.01M214.93%1.96M385.61%2.06M
Non-operating interest income -7.59%7.3M-20.81%1.59M-10.40%1.76M-4.37%1.97M----234.75%7.9M55.26%2.01M214.93%1.96M385.61%2.06M----
Other net income (expense) -61.29%-50K5.82%1.98M-144.29%-31K9,270.00%1.87M
Special income (charges) --------------0------------------0----
-Gain on sale of property,plant,equipment --------------0------------------0----
Other non- operating income (expenses) -61.29%-50K------------5.82%1.98M---31K------------9,270.00%1.87M
Income before tax -16.19%-49.38M-12.06%-15.03M-5.19%-10.48M-15.94%-13.08M-37.64%-10.79M-8.33%-42.49M-15.71%-13.42M16.79%-9.96M-32.78%-11.28M-9.42%-7.84M
Income tax 000000
Net income -16.19%-49.38M-12.06%-15.03M-5.19%-10.48M-15.94%-13.08M-37.64%-10.79M-8.33%-42.49M-15.71%-13.42M16.79%-9.96M-32.78%-11.28M-9.42%-7.84M
Net income continuous Operations -16.19%-49.38M-12.06%-15.03M-5.19%-10.48M-15.94%-13.08M-37.64%-10.79M-8.33%-42.49M-15.71%-13.42M16.79%-9.96M-32.78%-11.28M-9.42%-7.84M
Minority interest income
Net income attributable to the parent company -16.19%-49.38M-12.06%-15.03M-5.19%-10.48M-15.94%-13.08M-37.64%-10.79M-8.33%-42.49M-15.71%-13.42M16.79%-9.96M-32.78%-11.28M-9.42%-7.84M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -16.19%-49.38M-12.06%-15.03M-5.19%-10.48M-15.94%-13.08M-37.64%-10.79M-8.33%-42.49M-15.71%-13.42M16.79%-9.96M-32.78%-11.28M-9.42%-7.84M
Basic earnings per share -9.09%-0.36-10.00%-0.110.00%-0.08-11.11%-0.1-33.33%-0.0810.81%-0.330.00%-0.133.33%-0.08-12.50%-0.0914.29%-0.06
Diluted earnings per share -9.09%-0.36-10.00%-0.110.00%-0.08-11.11%-0.1-33.33%-0.0810.81%-0.330.00%-0.133.33%-0.08-12.50%-0.0914.29%-0.06
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More